Mosaic Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.29M Hold
14,986
1.62% 11
2025
Q4
$2.07M Hold
14,986
1.41% 16
2025
Q3
$1.92M Hold
14,986
1.37% 15
2025
Q2
$1.81M Hold
14,986
1.39% 15
2025
Q1
$1.67M Sell
14,986
-93
-0.6% -$9.9K 1.36% 15
2024
Q4
$1.47M Buy
15,079
+588
+4% +$62.7K 1.05% 24
2024
Q3
$1.67M Hold
14,491
1.18% 19
2024
Q2
$1.54M Sell
14,491
-461
-3% -$46.3K 1.11% 22
2024
Q1
$1.45M Buy
+14,952
New +$1.53M 1.16% 21

Other funds holding NVS

Mosaic Financial Group's NVS Position: Q1 2026 in Review

Mosaic Financial Group held its Novartis (NVS) position steady in Q1 2026 at 14,986 shares worth $2.29M. The position accounts for 1.62% of the portfolio, ranked #11.

Mosaic Financial Group first reported a position in NVS in Q1 2024 and has held it in 9 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Mosaic Financial Group held 14,986 shares of Novartis worth $2.29M as of Q1 2026.
  • Mosaic Financial Group left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 1.62% of Mosaic Financial Group's portfolio in Q1 2026, its #11 holding.
  • Mosaic Financial Group first reported a position in Novartis in Q1 2024 and has held it in 9 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Mosaic Financial Group's 13F filing for Q1 2026, filed 8 May 2026.